Time for a massive #RheumMadness thank you thread. This was a HUGE endeavor with so many contributors!

First, massive thanks to ALL OF YOU for participating! This project was always about inspiring collaborative learning. Thanks for playing, learning, debating, and sharing!
Second, huge thanks to the @RheumResearch Foundation for supporting this project through the Clinician Scholar Educator award. All aspiring educators in rheumatology, consider applying for this award! It connects you with an amazing community of educators.
Third, thank you to the fellow/resident members of the #RheumMadness leadership team: @AkiUdupa @GuyKatzMD @didemsayginmd and Allen Witt. It took a special kind of bravery to join this team and educate others on a podcast. You all are amazing!
Fourth, thank you to two of the best mentors ever: the fantastic @LisaCriscione and @Nephro_Sparks. This wouldn't have been possible without your support.
Fifth, thank you to the amazing #RheumRibbonPanel for putting those votes out there! Includes @jeffsparks @EBRheum @kristenyoung @TKTarrant, Eli Miloslavsky, Tayseer Haroun, and Beth Jonas. Read more about the panel: sites.duke.edu/rheummadness/2…
Finally - please know that #RheumMadness is just getting started! Future plans:
-More teams
-Teams won't just individual studies, they will be complex concepts
-Inclusion of Peds Rheum!

Keep your emails open for a Qualtrics survey. We want your feedback!
Oh my, left off the >40 fellows from 14 different fellowship programs who made 🔥scouting reports for the teams in the tournament.

They are the true ⭐️ of this tournament
@threadreaderapp please unroll

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with David Leverenz, MD

David Leverenz, MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DavidLeverenz

28 Mar
How well did the #RheumRibbonPanel match #RheumMadness participants' predictions in the #SeronegativeSixteen?

Belimumab for LN vs. Anifrolumab

Belimumab for LN: 5
Anifrolumab: 2

80% picked belimumab for LN

More in 🧵 below 👇 (1/8)
PEXIVAS vs. Avacopan

Avacopan: 4

66% picked avacopan

IgG4-RD Classification Criteria vs. RP Subtypes

IgG4-RD Classification Criteria: 5
RP Subtypes: 2

77% picked IgG4-RD Classification Criteria

Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!